Generated DCs

These DCs were generated from adherent peripheral blood monocytes and will subsequently be used as a vaccine for HLA-A1 and/or HLA-A2 positive patients with stage III/IV melanoma.

• biomaterial type
• monocyte

created over 16 years ago (2 March 2009)    last modified over 14 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]